Couldn't agree more. If anything i think the forecast of 130m ebitda for fy17 allows for some wriggle room on lgc prices (discount).
But right now fundamentals ignored for sentiment driven propaganda. No doubt it will turn. You just cant have balance sheet improvement and share price discount in the long run.
- Forums
- ASX - By Stock
- IFN Valuation
IFN
infragreen group limited
Add to My Watchlist
0.00%
!
$1.15

Couldn't agree more. If anything i think the forecast of 130m...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $155.4M |
Open | High | Low | Value | Volume |
$1.19 | $1.20 | $1.12 | $637.6K | 559.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14454 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 14868 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14454 | 1.140 |
1 | 28425 | 1.120 |
1 | 1600 | 1.110 |
3 | 102523 | 1.100 |
1 | 10000 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 14868 | 1 |
1.210 | 21405 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IFN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online